Work

494 Evaluating ERK1 2 Phosphorylation as a Predictive Biomarker for Survival in Recurrent Glioblastoma Patients: A REMARK Criteria-guided Analysis of a Clinical Trial Cohort Treated With Intracerebral PD-1 and CTLA-4 Blockade

Year: 2024

Type: conference-abstract

Source: Neurosurgery

DOI: 10.1227/neu.0000000000002809_494

Authors: Victor Andrés Arrieta, Johnny Duerinck, Kirsten B. Burdett, Wietse Geens, Julia K. Schwarze, Andrew Gould, Karl Habashy, Li Chen, Matthew McCord, Craig Horbinski, Hui Zhang, Roger Stupp, Bart Neyns, Adam M. Sonabend

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4392870472

Cites:

Cited by:

Related to: 10